News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Giampaolo Merlini, MD

Articles by Giampaolo Merlini, MD

Uniform Risk-Stratification and Response Criteria Are Paving the Way to Evidence-Based Treatment of AL Amyloidosis

ByGiovanni Palladini, MD, PhD,Giampaolo Merlini, MD

June 15th 2011

In less than a decade, the resources available to treat light chain (AL) amyloidosis have increased impressively.

Latest Updated Articles

Uniform Risk-Stratification and Response Criteria Are Paving the Way to Evidence-Based Treatment of AL Amyloidosis
June 15th 2011

Trending on CancerNetwork

Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC

FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma

The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes

Selinexor Combo Improves Spleen Volume Reduction in Myelofibrosis

Exploring the Role of Radiation Oncology in Kidney Cancer Awareness Month